-+ 0.00%
-+ 0.00%
-+ 0.00%

The UK Court Of Appeal Has Upheld The Validity Of Moderna's EP'949 Patent Against Pfizer/BioNTech

Benzinga·08/01/2025 10:13:30
Listen to the news
  • This decision affirms the High Court's initial ruling from July 2024 that the EP'949 patent is valid and infringed by Pfizer/BioNTech's COVID-19 vaccine, Comirnaty, which was subsequently appealed by Pfizer/BioNTech. 
  • With this ruling, the UK becomes the first jurisdiction globally to issue a second-instance decision confirming the validity of one of Moderna's core mRNA patents. The High Court's finding of infringement was not disputed by Pfizer/BioNTech on appeal.